Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Total 13F shares
-
24,392,678
-
Share change
-
+560,840
-
Total reported value
-
$1,025,469,934
-
Price per share
-
$42.04
-
Number of holders
-
90
-
Value change
-
+$23,046,207
-
Number of buys
-
44
-
Number of sells
-
46
Institutional Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q4 2018
As of 31 Dec 2018,
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,392,678 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, Redmile Group, LLC, BOXER CAPITAL, LLC, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., BB BIOTECH AG, FMR LLC, Point72 Asset Management, L.P., and ArrowMark Colorado Holdings LLC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.